Back

Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes

28 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Inflammatory mechanisms in vascular disease Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Johannes Benjamin Bernhard

Medical University of Vienna, Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils
Doctor S. Eiras (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial
Ms A. Ondracek (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Bone-marrow-derived nerve growth factor receptor-positive dendritic cells contribute to the suppression of arterial remodelling via apoptosis
Assistant Professor S. Takashima (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Phenylacetylglutamine causes a pathologic inflammation state and enhances atherosclerosis through the b2-adrenergic receptor cAMP PKA NF-kappaB pathway in diabetes.
Doctor L. Huang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model
Doctor B. Barta (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Inflammatory mechanisms in vascular disease

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial
thumbnail
Congress Presentation
The effect of proprotein convertase subtilisin/kexin type 9 inhibition on the plasma proteome: a SPIRE sub-study
thumbnail
Congress Presentation
PCSK9 inhibition: new insights

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources